First Time Loading...

LogicBio Therapeutics Inc
NASDAQ:LOGC

Watchlist Manager
LogicBio Therapeutics Inc Logo
LogicBio Therapeutics Inc
NASDAQ:LOGC
Watchlist
Price: 2.07 USD Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

LOGC Price Targets Summary
LogicBio Therapeutics Inc

There are no price targets for LOGC.
LOGC Lowest Forecast
Wall Street Target
Not Available
LOGC Average Forecast
Wall Street Target
Not Available
LOGC Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

LOGC Last Price Targets
LogicBio Therapeutics Inc

The latest public price target was made on May 17, 2022 by Unknown Analyst from Chardan Capital , who expects LOGC stock to rise by 93% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
Chardan Capital
4 USD
Upside 93%
1 year ago
May 17, 2022
Chardan Capital Maintains Buy on LogicBio Therapeutics, Lowers Price Target to $4
Benzinga
Unknown Analyst
JMP Securities
3 USD
Upside 45%
1 year ago
May 10, 2022
JMP Securities Maintains Market Outperform on LogicBio Therapeutics, Raises Price Target to $3
Benzinga
Unknown Analyst
Chardan Capital
Price Target 4 USD
Upside/Downside 93%
View Source
Unknown Analyst
JMP Securities
Price Target 3 USD
Upside/Downside 45%
View Source
LogicBio Therapeutics Inc Competitors:
Price Targets
SERA
Sera Prognostics Inc
74% Downside
300841
Chengdu Kanghua Biological Products Co Ltd
38% Upside
I
086890
Isu Abxis Co Ltd
123% Upside
VRTX
Vertex Pharmaceuticals Inc
20% Upside
SERA
Sera Prognostics Inc
74% Downside
300841
Chengdu Kanghua Biological Products Co Ltd
38% Upside
I
086890
Isu Abxis Co Ltd
123% Upside
VRTX
Vertex Pharmaceuticals Inc
20% Upside
002007
Hualan Biological Engineering Inc
40% Upside
S
SABS
SAB Biotherapeutics Inc
332% Upside
M
MLYS
Mineralys Therapeutics Inc
191% Upside
C
049960
Cell Biotech Co Ltd
378% Upside

Revenue
Forecast

Revenue Estimate
LogicBio Therapeutics Inc

The compound annual growth rate of LogicBio Therapeutics Inc's revenue for the next 2 years is -14%.

N/A
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
LogicBio Therapeutics Inc

Operating Income forecast
is not available for
LogicBio Therapeutics Inc

Net Income
Forecast

Net Income Estimate
LogicBio Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
What are analyst estimates?

See Also

Summary
LOGC intrinsic value, competitors valuation, and company profile.
DCF Valuation
LOGC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LOGC stock valuation using valuation multiples.
Wall Street Estimates
LOGC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LOGC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LOGC's stock price target?
Not Available

LOGC doesn't have any price targets made by Wall Street professionals.

What is LogicBio Therapeutics Inc's Revenue forecast?
Projected CAGR
-14%

The compound annual growth rate of LogicBio Therapeutics Inc's revenue for the next 2 years is -14%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.